Skip to main content
logo
Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
0.9837
-0.0463 (-4.50%)
At close: Sep 15, 2026, 4:00 PM EDT
1.020
+0.036 (3.69%)
After-hours: Sep 15, 2026, 7:43 PM EDT

Actuate Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
4.4313.168.642.9620.45
Cash & Short-Term Investments
4.4313.168.642.9620.45
Cash Growth
-31.83%52.28%192.08%-85.53%-
Prepaid Expenses
0.320.480.570.040.03
Total Current Assets
4.7513.649.21320.48
Long-Term Deferred Charges
0.450.390.11--
Total Assets
5.214.049.32320.48

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Accounts Payable
1.081.521.923.422.13
Accrued Expenses
2.734.186.883.52.21
Total Current Liabilities
3.815.718.86.924.34
Other Long-Term Liabilities
0.40.40.410.540.49
Total Liabilities
4.216.119.217.464.84

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Common Stock
00000
Additional Paid-In Capital
166.09162.53132.485.475.04
Retained Earnings
-165.1-154.61-132.38-105.09-80.35
Total Common Equity
0.997.920.1-99.63-75.31
Shareholders' Equity
0.997.920.1-4.4615.65
Total Liabilities & Equity
5.214.049.32320.48

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Cash (Debt)
4.4313.168.642.9620.45
Net Cash Growth
-31.83%52.28%192.08%-85.53%-
Net Cash Per Share
0.190.631.032.0616.89
Filing Date Shares Outstanding
24.0123.7119.531.691.21
Total Common Shares Outstanding
24.0123.2519.531.691.21
Working Capital
0.947.940.41-3.9316.14
Book Value Per Share
0.040.340.01-58.93-62.21
Tangible Book Value
0.997.920.1-99.63-75.31
Tangible Book Value Per Share
0.040.340.01-58.93-62.21
SEC Filings: 10-K · 10-Q